Odontis Ltd.

Tissue engineering of teeth

Developmental stage company formed in 2002 based on research by Professor Paul Sharpe, Head of Division of Craniofacial Biology and Biomaterials of the Dental Institute, Kings College London. The company has received an investment of £400,000 from the National Endowment for Science, Technology and the Arts.

Paul Sharpe, Prof., Founder
Valerie Joliffe
George Murlewski

Suite 4
46 Dorset Street
London W1U 7NB
UK
Phone: +44-(0)207-486-7456

The loss/replacement of teeth is currently done with dentures, bridges or synthetic/titanium post implants. Odontis Ltd. is hoping to be able to offer natural, live tooth substitutes. The buds, when implanted back into the patient, are expected to regenerate a living tooth that is embedded in associated bone and connective tissues. Laboratory investigations have shown that some cultured cell types can be induced to develop into teeth. This discovery is the basis of the company’s current research and development programme.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.